Qrons Inc. Engages American Capital Ventures for Investor Relations Services

Author's Avatar
Apr 12, 2019
Article's Main Image

MIAMI, FL / ACCESSWIRE / April 30, 2018 / Qrons Inc., (www.Qrons.com) (OTC PINK: QRON) a preclinical biotechnology company that is developing advanced cell-based solutions to combat neurological injuries today announced that it has engaged American Capital Ventures ("ACV"), a boutique provider of comprehensive investor relations services to micro- and small-cap companies, to provide investor relations services to the company.